V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20211966 | 20078734 | 1.58 | 75.05 | Palliative (P) | 2018-05-12 | 2018-05-12 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101464909 |
| 20211970 | 20078735 | 1.75 | 84 | Palliative (P) | 2017-04-21 | 2017-04-21 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101401744 |
| 20211971 | 20078736 | 1.76 | 65 | Palliative (P) | 2017-12-04 | 2017-12-18 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101003326 |
| 20211972 | 20078737 | 1.6 | 76.5 | Palliative (P) | 2018-12-23 | 2018-12-23 | Trial Unspecified | null | N | TRIAL UNSPECIFIED | 101572315 |
| 20211973 | 20078738 | 1.5 | 61 | Curative (C) | 2018-08-29 | 2018-09-18 | Capecitabine (21days) + Carboplatin | N | Y | CAPECITABINE + CARBOPLATIN | 100787554 |
| 20211978 | 20078739 | 1.74 | 74.5 | Palliative (P) | 2019-09-03 | 2019-10-03 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101061683 |
| 20211980 | 20078740 | 1.67 | 51.35 | Neo-adjuvant (N) | 2018-12-18 | 2018-12-19 | CAPECITABINE + CARBOPLATIN | N | N | CAPECITABINE + CARBOPLATIN | 100698540 |
| 20211986 | 20078741 | 1.74 | 48.4 | Neo-adjuvant (N) | 2017-11-30 | 2017-12-13 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101168022 |
| 20211990 | 20078742 | 0 | 0 | Neo-adjuvant (N) | 2020-10-01 | 2020-10-22 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101496912 |
| 20211993 | 20078743 | 1.5 | 74 | Neo-adjuvant (N) | 2017-12-03 | 2017-12-07 | Trial Unspecified | null | N | TRIAL UNSPECIFIED | 101459117 |
| 20211994 | 20078744 | 1.73 | 17.2 | Palliative (P) | 2016-03-06 | 2016-03-14 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100133556 |
| 20211998 | 20078745 | 1.75 | 0 | 03 | null | 2017-01-03 | CAPECITABINE + CARBOPLATIN | 2 | null | TRIAL UNSPECIFIED | 101787762 |
| 20211999 | 20078746 | 1.69 | 81 | Neo-adjuvant (N) | 2016-04-28 | 2016-04-28 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100329653 |
| 20212012 | 20078747 | 1.52 | 124 | Palliative (P) | 2016-08-17 | 2016-09-24 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101725810 |
| 20212019 | 20078748 | 1.7 | 72.5 | Curative (C) | 2017-08-15 | 2017-08-20 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100883081 |
| 20212021 | 20078749 | 1.9 | 84.6 | Palliative (P) | 2018-03-11 | 2018-03-11 | Trial Unspecified | null | N | TRIAL UNSPECIFIED | 101849690 |
| 20212024 | 20078750 | 1.71 | 73 | null | 2017-04-23 | 2017-05-25 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101614911 |
| 20212025 | 20078751 | 1.71 | 63 | null | 2016-07-15 | 2016-07-15 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100820467 |
| 20212029 | 20078752 | 1.61 | 69 | Palliative (P) | 2017-09-13 | 2017-09-13 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100617706 |
| 20212031 | 20078753 | 1.73 | 61.6 | 03 | 2018-01-04 | 2018-01-11 | CISPLATIN + FLUOROURACIL | 02 | null | CAPECITABINE + CARBOPLATIN | 101403759 |
| 20212032 | 20078754 | 0 | 0 | Palliative (P) | 2016-11-08 | 2016-12-23 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100102860 |
| 20212037 | 20078755 | 0 | 0 | Palliative (P) | 2017-06-06 | 2017-07-03 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100416495 |
| 20212045 | 20078756 | 1.7 | 57 | Palliative (P) | 2018-11-13 | 2018-11-15 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101448313 |
| 20212047 | 20078757 | 1.69 | 92.2 | Neo-adjuvant (N) | 2019-02-23 | 2019-03-03 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 100280753 |
| 20212051 | 20078758 | 1.59 | 87.1 | Curative (C) | 2016-05-09 | 2016-05-09 | CAPECITABINE + CARBOPLATIN | 02 | Y | CAPECITABINE + CARBOPLATIN | 100847081 |
| 20212052 | 20078759 | 1.85 | 56 | Curative (C) | 2018-03-13 | 2018-03-28 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 101534923 |
| 20212053 | 20078760 | 1.57 | 94 | Curative (C) | 2016-10-31 | 2016-11-11 | Capecitabine (21days) + Carboplatin | 02 | Y | CAPECITABINE + CARBOPLATIN | 100239610 |
| 20212054 | 20078761 | 1.71 | 102 | Neo-adjuvant (N) | 2017-12-17 | 2017-12-31 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100945805 |
| 20212059 | 20078762 | 1.66 | 100.8 | Palliative (P) | 2018-04-09 | 2018-04-16 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100101009 |
| 20212060 | 20078763 | 1.74 | 61.2 | Neo-adjuvant (N) | 2019-03-29 | 2019-04-15 | Trial Unspecified | 02 | Y | TRIAL UNSPECIFIED | 101315481 |
| 20212061 | 20078764 | 1.65 | 96.4 | Palliative (P) | 2017-09-18 | 2017-10-08 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101616026 |
| 20212062 | 20078765 | 1.65 | 69.6 | Palliative (P) | null | 2016-08-15 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101362952 |
| 20212064 | 20078766 | 1.47 | 82.5 | Neo-adjuvant (N) | 2018-05-15 | 2018-05-21 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101324258 |
| 20212065 | 20078767 | 1.72 | 108.95 | Palliative (P) | 2018-01-31 | 2018-02-14 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101713304 |
| 20212066 | 20078768 | 1.74 | 82.2 | Curative (C) | 2019-02-03 | 2019-02-08 | Cisplatin +Fluorouracil (3 wk) | 02 | Y | CISPLATIN + FLUOROURACIL | 100932306 |
| 20212067 | 20078769 | 1.84 | 60.1 | Palliative (P) | 2016-05-07 | 2016-05-28 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101124124 |
| 20212068 | 20078770 | null | 84.6 | Curative (C) | null | 2016-07-25 | Doxorubicin chemoembolisation | 02 | Y | DOXORUBICIN EMBOLISATION | 100278402 |
| 20212069 | 20078771 | 1.6 | 83 | Palliative (P) | 2019-02-20 | 2019-02-20 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100624876 |
| 20212070 | 20078772 | null | 54 | Neo-adjuvant (N) | 2017-10-15 | 2017-11-04 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101820944 |
| 20212071 | 20078773 | 0 | 0 | Palliative (P) | null | 2019-02-20 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101770246 |
| 20212072 | 20078774 | 1.53 | 69.3 | Neo-adjuvant (N) | 2017-09-16 | 2017-09-30 | Capecitabine (21days) + Carboplatin | 02 | Y | CAPECITABINE + CARBOPLATIN | 100836957 |
| 20212073 | 20078775 | 1.68 | 57.3 | null | 2019-04-30 | 2019-05-14 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100394057 |
| 20212074 | 20078776 | 0 | 0 | Palliative (P) | 2016-10-19 | 2016-11-12 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101010025 |
| 20212075 | 20078777 | 1.7 | 81.2 | Neo-adjuvant (N) | 2020-01-08 | 2020-01-13 | CAPECITABINE + CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 100766917 |
| 20212076 | 20078778 | 1.71 | 95.6 | Curative (C) | 2017-07-18 | 2017-07-30 | CISPLATIN + FLUOROURACIL | 02 | Y | CISPLATIN + FLUOROURACIL | 101466302 |
| 20212080 | 20078779 | 1.71 | 75.6 | null | 2018-02-14 | 2018-02-17 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100503967 |
| 20212081 | 20078780 | 0 | 0 | Palliative (P) | 2019-05-30 | 2019-06-06 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 100658239 |
| 20212082 | 20078781 | 1.74 | 53.2 | Palliative (P) | 2016-11-20 | 2016-12-03 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100467371 |
| 20212083 | 20078782 | 1.73 | 88.7 | Palliative (P) | 2017-12-30 | 2018-01-08 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100569767 |
| 20212084 | 20078783 | 1.7 | 58.55 | Adjuvant (A) | 2017-01-30 | 2017-02-14 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101821664 |